Добавил:
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Color Atlas of Neurology

.pdf
Скачиваний:
195
Добавлен:
11.08.2013
Размер:
18.87 Mб
Скачать

 

 

 

 

Myopathies

 

 

Axon terminal

 

 

 

Mitochon-

 

Synaptic vesicle containing ACh*

 

drion

 

 

 

 

 

 

 

Basement

 

 

 

 

 

membrane

 

Complement-mediated AChR lysis

 

 

 

 

 

Calcium channel autoantibodies

 

 

 

 

 

(reduced ACh release)

Muscle

Muscle

Normal

AChR

 

 

 

 

 

Release of ACh

 

 

 

 

and

 

 

 

 

 

 

binding

(ACh-effect

 

Nerve

 

AChR autoantibody

Loss of AChR

 

 

 

 

MG

diminished)

 

Peripheral

 

Neuromuscular synapse–Pathogenesis

 

 

 

 

 

 

LEMS

 

 

 

 

Ptosis

 

 

Faciopharyngeal

 

Intravenous

 

 

 

edrophonium chloride

 

weakness

 

 

 

 

 

 

 

 

Exercise-induced muscle weakness

 

Normal muscle strength (after

 

 

 

 

 

edrophonium chloride)

 

 

 

Myasthenia gravis

 

 

Amplitude reduction (decrement

 

Increase in amplitude

 

from 1st to 5th stimulus)

 

 

 

 

(increment > 3.5 times higher than baseline)

 

 

 

 

 

 

 

Low

 

 

 

 

starting amplitude

 

Repeated low-frequency stimulation

 

 

 

(3 Hz, trapezius m., MG)

 

 

 

 

*ACh = acetylcholine

Repetitive nerve stimulation

Repeated high-frequency stimulation

343

(20 Hz, abductor digiti quinti m., LEMS)

 

Rohkamm, Color Atlas of Neurology © 2004 Thieme

All rights reserved. Usage subject to terms and conditions of license.

Myopathies

Myositis

The myositides (inflammatory myopathies) are a heterogeneous group of disorders, causing three distinct clinical syndromes: polymyositis (PM), dermatomyositis (DM), and inclusion body myositis (IBM).

 

! Pathogenesis

 

 

 

Muscle

Most myositides found in the temperate zones

mation and fibrosis and loss of muscle fibers. In

 

are autoimmune diseases of unknown cause,

 

characterized histologically by muscle inflam-

and

PM, cytotoxic CD8+ T cells penetrate and damage

muscle fibers

( intramuscular cellular infil-

Nerve

trates). CD8+ T cell activation is induced by ab-

normal expression of class I HLA antigens on the

 

Peripheral

surface of the muscle fibers, which are normally

HLA-negative. DM is thought to be largely due to

 

 

antibodies against blood vessels within muscle,

 

which activate the complement system (mem-

 

brane attack complex). Vascular endothelial

 

damage ultimately leads to ischemia and death

 

of muscle tissue ( perifascicular atrophy). In-

 

flammatory T cells and macrophages migrate

 

into muscle and cause further damage. IBM is of

 

unknown pathogenesis. Infectious myositis may

 

be due to bacteria, viruses, parasites, or fungi.

 

! Syndromes

 

 

 

 

 

Polymyositis (PM) begins with weakness of the

 

proximal muscles of the lower limbs, which

 

then progresses and slowly spreads to the upper

 

limbs. The deltoid and neck flexor muscles are

 

commonly involved. Dysphagia may be present.

 

The involved muscles eventually become

 

atrophic. In overlap syndrome, myositis appears

 

together

with

another autoimmune

disease,

 

e. g., progressive systemic

sclerosis,

systemic

 

lupus erythematosus, rheumatoid arthritis, pol-

 

yarteritis nodosa, polymyalgia rheumatica, or

 

Sjögren syndrome. Myalgia is often the major

 

symptoms in patients with PM, as also in

 

patients

with

hypereosinophilia

syndrome

 

(Churg–Strauss

syndrome)

or

eosinophilic

 

fasciitis (Shulman disease).

 

 

 

 

Dermatomyositis (DM) progresses more rapidly

 

than PM and is distinguished from it mainly by

344the bluish-red or purple (heliotrope) rash found on exposed areas of the skin (eyelids, cheeks,

neck, chest, knuckles, and extensor surfaces of

the limbs). Small hemorrhages and telangiectasias are found in the nailbeds; affected children may have subcutaneous calcium deposits. Cancer accompanies DM six times more frequently than PM; DM is also associated with scleroderma and mixed connective tissue disease.

Inclusion body myositis (IBM) is characterized by distal (sometimes asymmetric) weakness and muscle atrophy, mainly in the lower limbs (plantar flexors), with early loss of the quadriceps reflexes. There are both sporadic and hereditary forms of IBM (see also p. 252).

! Diagnosis

The myositides are diagnosed by history and physical examination, elevated serum concentration of sarcoplasmic enzymes (particularly CK-MM), and characteristic findings on EMG and muscle biopsy. Muscle atrophy can also be assessed with various imaging techniques (CT, MRI, ultrasonography). The presence of antibodies in association with a connective tissue disease may be relevant to the diagnosis (p. 180).

! Treatment

PM and DM are treated by immune suppression, e. g., with corticosteroids, azathioprine, or intravenous gammaglobulin (ivig). Physical therapy is begun once the patient’s condition has stabilized. IBM may respond to intravenous immunoglobulin therapy.

Rohkamm, Color Atlas of Neurology © 2004 Thieme

All rights reserved. Usage subject to terms and conditions of license.

Myopathies

Cervical muscle weakness

Proximal muscle weakness and atrophy

Ischemic lesion of muscle fiber

Perifascicular atrophy (DM; cross section of muscle fiber)

Lymphomonocytic infiltrate in muscle, vessel (PM, cross section of muscle fiber)

Lid edema

Facial erythema

Proximal muscle weakness

Telangiectasis,

Polymyositis (PM) hemorrhage (nailbed)

Erythema in joint region (extensor side)

Dermatomyositis (DM)

Distal muscle atrophy

Bleeding

Inclusion body myositis (IBM)

Butterfly rash (lupus erythematosus)

Peripheral Nerve and Muscle

345

Rohkamm, Color Atlas of Neurology © 2004 Thieme

All rights reserved. Usage subject to terms and conditions of license.

Neuromuscular Disorders

 

Muscle Pain (Myalgia)

pain induced by normally nonpainful stimuli

 

and is explained by the sensitization of nocicep-

 

 

 

 

 

 

 

Myalgia is an aching, cramping, or piercing pain

tors by pain-related substances such as brady-

 

in muscle. It is triggered by stimulation of noci-

kinin, serotonin, and prostaglandin. A “charley-

 

ceptors (p. 108). Pressure or traction on a muscle

horse” is a type of myalgia that normally begins

 

causes myalgia that subsides once the mechani-

8–24 hours after muscle overuse (simultaneous

 

cal stimulus is removed, while inflammatory

stretching and contraction) and lasts 5–7 days. It

 

and other lesions in muscle cause persistent and

is caused by an inflammatory reaction to muscle

 

gradually increasing myalgia. Muscle ischemia

fiber damage. Myalgia can be triggered by dis-

Muscle

and/or metabolic dysfunction are reflected by

orders whose primary pathology lies anywhere

myalgia occurring only during muscle activity.

in the nervous system (peripheral nerve, spinal

 

 

Myalgia includes allodynia, which is defined as

cord, brain).

and

! Causes of Myalgia

 

 

 

 

 

 

 

Nerve

 

 

 

 

 

Type of Myalgia

Selected Causes

 

 

 

 

 

 

 

Localized myalgia

"

 

 

Peripheral

 

"

Hematoma

Trauma, coagulopathy

 

 

"

Myositis

" Infectious: Streptococcal infection, trichinosis, influenza, epidemic pleurodynia. Non-

 

 

 

 

 

infectious: Nodular focal myositis, eosinophilic fasciitis, sarcoidosis, myositis ossifi-

 

 

 

 

 

cans

 

 

 

"

Ischemic

" Arteriosclerosis (intermittent claudication), embolism

 

 

"

Toxic-metabolic

" Acute alcoholic myopathy, metabolic myopathy (pp. 402, 405)

 

 

"

Overactivity

" Stiff-man syndrome, neurogenic myotonia, tetanus, strychnine poisoning, amyo-

 

 

"

 

"

trophic lateral sclerosis, tetany

 

 

 

Exercise-

Metabolic myopathy, arteriosclerosis, physical exertion

 

 

"

induced

"

 

 

 

 

Parkinsonian

Rigidity

 

 

 

"

Muscle spasm

" Polyneuropathy, metabolic disorder (electrolyte imbalance, uremia, thyroid dysfunc-

 

 

"

 

"

tion)

 

 

 

Pain at rest

Restless legs syndrome, painful legs and moving toes syndrome

 

 

Generalized myalgia

 

 

 

 

 

"

Myositis

"

Polymyositis/dermatomyositis (p. 344)

 

 

"

Toxic-metabolic

" Hypothyroidism, medications2, mitochondrial myopathy (pp. 340, 402, 405)

 

 

"

Other

" Polymyalgia rheumatica, amyloidosis, osteomalacia, Guillain–Barré syndrome,

 

 

 

 

 

porphyria, hypothyroidism, corticosteroid withdrawal, fibromyalgia

 

 

 

 

 

 

 

(Adapted from Layzer, 1994)

1 E.g., emetine, lovastatin, and ε-aminocaproic acid.

 

Rhabdomyolysis

stroke, delirium tremens, status epilepticus), by

 

toxic substances (see below), and by infectious

 

 

 

Local or generalized damage to skeletal muscle

disease (bacterial sepsis, influenza, coxsack-

 

can cause myoglobinuria and an elevated serum

ievirus or echovirus infection).

 

concentration of creatine kinase, usually accom-

 

 

panied by the acute onset of proximal or diffuse

Malignant Hyperthermia (MH)

 

weakness, with myalgia, muscle swelling, and

 

 

 

general manifestations including nausea, vomit-

This life-threatening disorder of skeletal muscle

 

ing, headache, and sometimes fever. The urine

function is characterized by hyperthermia,

 

may be discolored at the onset of symptoms or

muscle rigidity, hyperhidrosis, tachycardia, cya-

 

several hours later. Rhabdomyolysis can be

nosis, lactic acidosis, hyperkalemia, massive

 

 

caused by certain types of myopathy (e. g., poly-

elevation of the serum creatine kinase concen-

346

myositis, central core disease, metabolic my-

tration, and myoglobinuria. It is induced by an-

 

opathies; pp. 402, 405), by muscle strain or

esthetic agents such as halothane and succinyl-

 

trauma (long-distance walking or running, heat

choline. The predisposition to MH is inherited as

 

Rohkamm, Color Atlas of Neurology © 2004 Thieme

All rights reserved. Usage subject to terms and conditions of license.

Neuromuscular Disorders

an autosomal dominant trait (gene loci: 19q13.1, 17q11–24, 7q12.1, 5p, 3q13.1, 1q32). The creatine kinase level may be chronically elevated in susceptible individuals, who can be identified with an in vitro contracture test performed in specialized laboratories. Persons suffering from central core disease, multicore disease, and King–Denborough syndrome (dwarfism, skeletal anomalies, ptosis, high palate) are also at risk for MH. Treatment: dantrolene.

Malignant neuroleptic syndrome clinically resembles MH; unlike MH, however, it is usually of subacute onset (days to weeks), it is not hereditary, and it is triggered by psychotropic drugs (haloperidol, phenothiazines, lithium). Malignant neuroleptic syndrome can also be induced by abrupt withdrawal of dopaminergic agents in patients with Parkinson disease.

Toxic Neuromuscular Syndromes

The muscle fiber lesions regress if the responsible substance is eliminated in timely fashion (Table 75, p. 405).

Myopathy in Endocrine Disorders

Hyperthyroidism or hypothyroidism, hyperparathyroidism, Cushing syndrome, steroid myopathy, and acromegaly all cause proximal weakness, while Addison disease and primary hyperaldosteronism usually cause generalized weakness. Timely correction of the endocrine disorder or withdrawal of steroid drugs is usually followed by improvement.

Critical Illness Polyneuropathy (CIP)

and Critical Illness Myopathy (CIM)

Sepsis is the most common cause not only of encephalopathy (see p. 312) but also of CIP and CIM. CIP is an acute, reversible, mainly axonal polyneuropathy. It causes distal, symmetric weakness with prominent involvement of the muscles of respiration, resulting in prolonged ventilator dependence and delayed mobilization. CIM causes generalized weakness. The clinical differentiation of CIM and CIP is difficult and often requires muscle biopsy.

Paraneoplastic Syndromes

(Table 76, p. 406)

Distant neoplasms can affect not only the CNS (see p. 388) but also the PNS and skeletal muscle. Remarkably, paraneoplastic syndromes sometimes appear months or years before the underlying malignancy becomes clinically manifest. Paraneoplastic neuromuscular syndromes typically present with marked weakness of subacute onset (i.e., developing over several days or weeks).

Peripheral Nerve and Muscle

347

Rohkamm, Color Atlas of Neurology © 2004 Thieme

All rights reserved. Usage subject to terms and conditions of license.

348

Rohkamm, Color Atlas of Neurology © 2004 Thieme

All rights reserved. Usage subject to terms and conditions of license.

4 Diagnostic Evaluation

!History and Physical Examination

!Additional Studies

Rohkamm, Color Atlas of Neurology © 2004 Thieme

All rights reserved. Usage subject to terms and conditions of license.

Diagnostic Evaluation

350

History and Physical Examination

A detailed description of diagnostic evaluation procedures can be found in the textbooks listed on p. 409. The goals of history-taking, physical examination, and additional testing (if necessary) are:

!Data collection (manifestations of disease)

!Localization of the lesion

!Provision of an etiological diagnosis

"Data Collection

The diagnostic process begins with the history and physical examination. The history provides information about the patient’s experience of illness, the temporal course of symptom development, and potentially relevant familial, social, occupational, and hereditary factors. An inaccurate or incomplete history is a frequent cause of misdiagnosis.

History. The physician engages the patient in a structured conversation about the manifestations of the illness. The physician must remember that the patient is the “expert” in this situation, as the patient alone knows what is troubling him (though perhaps helpful information can also be obtained from a close relative or friend). The physician aims to obtain accurate information on the nature, location, duration, and intensity of the symptoms by listening patiently and asking directed questions in an atmosphere of openness and trust. Questionnaires, computer programs, and ancillary personnel cannot be used for primary his- tory-taking, as they do not enable the construction of a trusting physician–patient relationship (though they may provide useful additional information at a later stage). Some important elements of the case history are as follows.

!Nature of symptoms. The physician must ascertain, by detailed questioning if necessary, that he understands the patient’s complaints in the same sense that the patient means to convey. “Blurred vision” may mean diplopia, “dizziness” may mean gait ataxia, “headache” may mean hemicrania, “numbness” may mean paresthesia—but patients may use all of these terms with other meanings as well.

!Severity of symptoms. Quality and intensity of symptoms, activities with which they interfere.

!Onset of symptoms. When, where, and over what interval of time did the symptoms arise?

!Time course of symptoms. How did they develop? Are they constant or variable? Are there any exacerbating or alleviating factors?

!Accompanying symptoms, if present.

!Past history of similar symptoms.

!Previous illnesses and their outcome.

!Social, occupational, and family history.

!Medications, smoking, alcohol abuse, substance abuse, toxic exposures.

!Previous diagnostic studies and treatment.

!Information from third parties may be needed for patients with aphasia, confusion, demen-

tia, or impairment of consciousness.

Physical examination. The general and neurological physical examination may yield important clues to the disease process, but only if the examiner has the requisite knowledge of the underlying principles of (neuro-)anatomy, (neuro-)physiology, and (neuro-)pathology. The examination is guided by the case history, i.e., the patient’s complaints and general physical condition determine what the examiner looks for in the examination. The unselective, “shotgun” application of every possible technique of neurological examination in every patient is not only a waste of time and money; it generally only creates confusion rather than clarifying the search for the diagnosis. The neurological examination of small children, patients with personality changes or mental illness, and unconscious patients poses special challenges.

Important elements of the neurological examination include:

!Inspection. Dress, appearance, posture, movements, speech, gestures, facial expression.

!Mental Status. Orientation (to person, place, and time), attention, concentration, memory, thought processes, language function, level of consciousness.

!Cranial nerves. Olfaction, pupils, visual fields, eyegrounds, eye movements, facial movement, facial sensation, hearing, tongue movements, swallowing, speaking, reflexes.

!Motor function. Muscular atrophy/hypertrophy, spontaneous movements, coordination, paresis, tremor, dystonia, muscle tone.

Rohkamm, Color Atlas of Neurology © 2004 Thieme

All rights reserved. Usage subject to terms and conditions of license.

History and Physical Examination

!Reflexes (p. 40).

!Sensory function. The findings of sensory testing are heavily influenced by the patient’s “sensitivity” and ability to cooperate. Vague sensory abnormalities without other neurological deficits are difficult to classify; their interpretation requires a good knowledge of the underlying neuroanatomy (pp. 32ff, 106f).

!Posture, station, and gait. The observation and testing of posture, station, and gait provides important information about a possible motor deficit (p. 42 ff).

!Autonomic function. The patient is questioned about bladder function, bowel movement/control, sexual function, blood pressure, cardiac function, and sweating, and is examined as needed.

"Localization of the Lesion

The findings of the history and physical examination findings are then related to dysfunction of a particular neuroanatomical structure(s) (p. 2 ff) or neurophysiological process (p. 40 ff); the site of the patient’s problem is thus localized (topical diagnosis).

" Provision of an Etiological Diagnosis

Once the site of the problem is localized, it must be determined whether it is due to a structural lesion (e. g., hemorrhage, nerve compression, or infection) or a functional disturbance (e. g.,

epileptic seizure, migraine, or Parkinson disease). The line between structural and functional pathology is not perfectly defined, as there is constant interaction between these two levels; at the same time, considerations of etiology and pathogenesis also influence data interpretation. The diagnostic process ideally ends in the diagnosis of a specific disease entity (nosological diagnosis).

Additional Diagnostic Studies

The clinical diagnosis may be considered firmly established by the history and physical examination alone in many cases, e. g., migraine or Parkinson disease. Additional diagnostic studies are merely confirmatory and are generally not needed unless doubt arises as to the diagnosis, e. g., if an epileptic seizure or new type of headache should appear.

Additional studies are needed, however, if there is no other way to decide among several diagnostic possibilities remaining after thorough his- tory-taking and physical examination. The number and type of studies needed differ from case to case. Studies that are costly or fraught with nonnegligible risk should never be ordered except to answer a clearly stated diagnostic question. The potential benefits of a proposed study must always be weighed against its risks and cost.

" Laboratory Tests

Table 77, p. 407

Diagnostic Evaluation

351

Rohkamm, Color Atlas of Neurology © 2004 Thieme

All rights reserved. Usage subject to terms and conditions of license.

Diagnostic Evaluation

Neurophysiological and Neuropsychological Tests

" Neurophysiological Tests

Test/Purpose

Risks

Comments

 

 

 

Electroencephalography: To assess elec-

Surface electrodes: none

Sphenoid, subdural or depth re-

trical activity of the brain1

Needle electrodes: infec-

cording3 for special questions relevant

 

tion

to the (preoperative) diagnostic eval-

 

Induction of seizures by

uation of epilepsy

 

 

 

provocative methods2

 

Evoked potentials (EPs):

 

 

 

! VEPs4: Study of optic nerve, optic

!

None

! Used mainly to diagnose prechias-

chiasm and optic tract

 

 

matic lesions

! AEPs5: Study of peripheral and cen-

!

None

! Used mainly for diagnosis of multi-

tral segments of the auditory path-

 

 

ple sclerosis, tumors of the poste-

way6

 

 

rior cranial fossa, brain stem le-

 

 

 

sions causing coma or brain death,

! SEPs7: Study of somatosensory sys-

 

 

and intraoperative monitoring

!

None

! Used to assess proximal peripheral

tems8

 

 

nerve lesions (plexus, roots) and

 

 

 

spinal cord or parietal lobe lesions

! MEPs9: Study of corticospinal

!

May induce epileptic

! Pyramidal tract lesions, motor neu-

motor pathway

 

seizures. Contraindica-

ron lesions, root compression,

 

 

tions: cardiac

plexus lesions, stimulation of deep

 

 

pacemakers, metal

nerves, differential diagnosis of

 

 

prostheses in the target

psychogenic paresis

 

 

area, pregnancy, un-

 

 

 

stable fractures

 

Electromyography: Study of electrical

Contraindication:

Provides information on motor unit

activity in muscle

coagulopathy. Risk of in-

disorders in patients with peripheral

 

jury in special studies11

nerve lesions or myopathies. Not dis-

 

 

 

ease-specific. Disposable needles

 

 

 

should be used to prevent spread of

 

 

 

infectious disease10

Electroneurography: Measurement of

Needle recordings con-

Localization (proximal, distal, conduc-

motor and sensory conduction veloci-

traindicated in patients

tion block) and classification (axonal,

ties.

with coagulopathy

demyelinating) of peripheral nerve le-

 

 

 

sions12

Electro-oculography: To record and

Caloric testing with water

Diagnosis and localization of periph-

assess eye movements and/or nystag-

contraindicated in patients

eral and central vestibular lesions.

mus

with perforated eardrums

Differentiation of saccades

 

 

 

 

1 For assessment of epilepsy, localized pathology (neoplasm, trauma, meningoencephalitis, infarct) or generalized pathology (intoxication, hypoxia, metabolic encephalopathy, Creutzfeldt–Jakob disease, coma, brain death), for sleep analysis (polysomnography), or to monitor the course of such conditions. 2 Photostimulation, hyperventilation, sleep, sleep withdrawal. 3 For diagnostic assessment before epilepsy surgery, in specialized centers.

4 Visual EPs. 5 Acoustic EPs. 6 Peripheral nerve and cochlear lesions are mainly studied audiometrically, and peripheral and central disorders by electro-oculography or posturography. 7 Somatosensory EPs. 8 Functional assessment of sensory pathways (p. 104) by tibial, median, ulnar, and trigeminal nerve stimulation. 9 Motor EPs. 10 Particularly Creutzfeldt–Jakob disease, hepatitis, AIDS. 11 Examples: Pneumothorax in study of the serratus anterior m., perforation of the rectal wall in study of the anal sphincter. 12 F-wave measurement for localization of proximal nerve damage, H-reflex in S1 syndrome.

 

" Neuropsychological Tests

tion suggest the possibility of mental illness or

 

of mental dysfunction due to neurological dis-

 

Comprehensive testing of cognitive function,

 

ease. Objectives: Accurate detection and effec-

352

behavior, and affective processes, perhaps in

tive monitoring, prognostication, identification

 

collaboration with a neuropsychologist, is re-

of etiology, and treatment of mental disorders

 

quired when the history and physical examina-

(p. 122 ff).

 

Rohkamm, Color Atlas of Neurology © 2004 Thieme

All rights reserved. Usage subject to terms and conditions of license.

Соседние файлы в предмете Нормальная анатомия